Valvular & structural heart diseaseCohort study

Incidence, Predictors and Outcomes of Bleeding Following Transcatheter Tricuspid Valve Repair

JACC Cardiovasc IntervPublished

  • Retrospective analysis of an international multicentre registry

Authors' conclusion

BARC major bleeding occurs in about 11% of patients following transcatheter tricuspid valve repair and is a major determinant of in-hospital and 1-year death.

Study context

Population
Patients undergoing transcatheter tricuspid valve repair (TriValve registry)
Participants
440 patients
Exposure
Major bleeding vs no major bleeding
Outcome
BARC bleeding (types 2, 3 and 5), its predictors and prognostic implications
Follow-up
Within 1 year

Main finding

As reported in the abstract

BARC major bleeding incidence

Bleeding Academic Research Consortium (BARC) major bleeding incidence (50 patients)

11.4%

Observational data: associations, not effects.

Further findings

Predictors of BARC major bleeding · within 1 year

Comparisonadjusted OR (95% CI)P value
Postprocedural tricuspid regurgitation severity1.83 (1.12–3.01)P = 0.02
Higher systolic pulmonary artery pressures1.61 (1.16–2.24)P = 0.0048
Increasing procedure duration1.49 (1.00–2.22)P = 0.049
Concomitant oral anticoagulation · not associated with bleeding1.51 (0.74–3.10)P = 0.30

Outcomes associated with bleeding

Comparisonadjusted HR (95% CI)P value
Bleeding · 1-year death or all-cause hospital readmission2.41 (1.39–4.19)P = 0.002
Bleeding · all-cause death3.55 (1.75–7.21)P = 0.0004
Bleeding · CV death3.72 (1.62–8.52)P = 0.002
Outcomeadjusted OR (95% CI)P value
Outcomes associated with bleeding — Major bleeding · in-hospital death106 (1.31–8,553)P = 0.04

Original publication

Incidence, Predictors and Outcomes of Bleeding Following Transcatheter Tricuspid Valve Repair. JACC Cardiovasc Interv. Published 23 March 2026. doi:10.1016/j.jcin.2026.01.288

Summarised from the published abstract; every number is checked against it